Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABUNDIA GLOBAL IMPACT GROUP, INC.HUSA · Entity 7206 | Director | June 20, 2024 | June 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABUNDIA GLOBAL IMPACT GROUP, INC.
Report date June 20, 2024 · Filed June 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.21 · Expires 2034-06-20 | Direct | 20,000 |
Reported balance
After 2024-06-20 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-06-20 · Grant · Acquired 20,000 · Balance 20,000 F1: The options were granted on June 20, 2024 and are exercisable six months from the date of grant, subject to vesting. The option vests 20% on the date of grant and 80% nine months from the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.34 · Expires 2028-04-13 | Direct | 666 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 666 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.03 · Expires 2028-06-05 | Direct | 4,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 4,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2029-06-13 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 40,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.45 · Expires 2030-11-10 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 150,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2031-07-22 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 20,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.91 · Expires 2032-09-20 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 20,000 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.09 · Expires 2033-06-27 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 20,000 |
| Common StockSEC Table I · non-derivative | Direct | 172,976 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 172,976 |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $2.46 · Expires 2029-09-18 | Direct | 46,400 |
Reported balance
Holding disclosure · report date 2024-06-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 46,400 |
Filing footnotes · ownership attribution and instrument terms
F1: The options were granted on June 20, 2024 and are exercisable six months from the date of grant, subject to vesting. The option vests 20% on the date of grant and 80% nine months from the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2024 Filed Jun 21, 2024 16:14 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001336301-24-000003 · primary_doc.xml · derivative · entry 10 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-06-20 F1 · derivative.exercise_date: The options were granted on June 20, 2024 and are exercisable six months from the date of grant, subject to vesting. The option vests 20% on the date of grant and 80% nine months from the date of grant. Read SEC document |
| June 27, 2023 Filed Jun 28, 2023 23:47 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.09 | $0.00 |
DisclosureSEC source: 0001191085-23-000003 · primary_doc.xml · derivative · entry 9 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-06-27 F1 · derivative.exercise_date: The options were granted on June 27, 2023 and are exercisable six months from the date of grant, subject to vesting. The option vests 20% on the date of grant and 80% nine months from the date of grant. Read SEC document |
| May 18, 2023 Filed May 18, 2023 22:40 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | PurchaseCommon Stock | 15,000 | $2.24 | $33,525.00 |
DisclosureSEC source: 0001191085-23-000001 · primary_doc.xml · nonDerivative · entry 1 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,976 Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 21:35 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001191085-22-000004 · primary_doc.xml · derivative · entry 8 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-09-20 F1 · derivative.exercise_date: The options were granted on September 20, 2022 and exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 8-% nine months from the date of grant. Read SEC document |
| September 02, 2022 Filed Sep 2, 2022 20:40 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | PurchaseCommon Stock | 15,000 | $4.37 | $65,550.00 |
DisclosureSEC source: 0001191085-22-000001 · primary_doc.xml · nonDerivative · entry 1 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,976 Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 18:48 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001191085-21-000002 · primary_doc.xml · derivative · entry 7 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-07-22 F1 · derivative.exercise_date: The options were granted on July 22, 2021 and are exercisable 6 months from the date of grant, subject to vesting. The option vests 20% on date of grant and 80% nine months from the date of grant. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:17 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | SaleCommon Stock | 16,715 | $2.63 | $43,960.45 |
DisclosureSEC source: 0001191085-21-000001 · primary_doc.xml · nonDerivative · entry 1 SCHOONOVER JAMES A · CIK 0001191085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,976 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 02:18 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001191085-20-000001 · primary_doc.xml · derivative · entry 8 SCHOONOVER JAMES A · CIK 0001191085 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-11-10 Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 20:42 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | PurchaseWarrant · Derivative | 580,000 | Not disclosed Strike: $0.20 | Not disclosed |
DisclosureSEC source: 0001191085-19-000002 · primary_doc.xml · derivative · entry 7 SCHOONOVER JAMES A · CIK 0001191085 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,000 Underlying: Common Stock · 580,000 shares Expires 2029-09-18 F2 · price: Warrants were issued in connection with a purchase of a promissory note. There is no separate purchase price for the warrants. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 21:45 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001336301-19-000003 · primary_doc.xml · derivative · entry 6 SCHOONOVER JAMES A · CIK 0001191085 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2029-06-13 Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:17 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | PurchaseCommon Stock | 11,000 | $0.20 | $2,167.00 |
DisclosureSEC source: 0001191085-18-000003 · primary_doc.xml · nonDerivative · entry 2 SCHOONOVER JAMES A · CIK 0001191085 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,996,138 Read SEC document |
| December 18, 2018 Filed Dec 20, 2018 21:17 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | PurchaseCommon Stock | 22,000 | $0.20 | $4,422.00 |
DisclosureSEC source: 0001191085-18-000003 · primary_doc.xml · nonDerivative · entry 1 SCHOONOVER JAMES A · CIK 0001191085 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,985,138 Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 20:46 UTC | ABUNDIA GLOBAL IMPACT GROUP, INC. HUSA · Entity 7206 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001336301-18-000003 · primary_doc.xml · derivative · entry 6 SCHOONOVER JAMES A · CIK 0001191085 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-06-05 F2 · derivative.exercise_date: The options were granted on June 5, 2018 and are exercisable six months from the date of grant, subject to vesting. The options vest 20% on the date of grant and 80% nine months from the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.